Test cyclosporine versus steroids for DRESS skin reaction
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial compares two medicines—cyclosporine and steroid treatment—for a rare, serious drug reaction called DRESS. It aims to see which treatment controls the illness more safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18+ years old).
- Your DRESS diagnosis is likely based on a RegiSCAR score higher than 4.
- You do not have active sepsis (a dangerous body-wide infection).
- You do not have active hepatitis B or C, or active tuberculosis.
- You are not allergic to steroids or cyclosporine.
- Your kidney function is not too low (eGFR is 30 or higher), unless you are on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This trial tests a targeted medicine for a severe drug reaction called DRESS, which can cause rash, fever, and organ problems. The goal is to see if the treatment helps control the reaction and improves recovery.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
This study collects skin and blood samples from adults who have a serious rash caused by medicines. The goal is to better understand these reactions and how to diagnose them sooner and more accurately.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
Hear when a new DRESS Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.